In this study we demonstrate that riociguat, a sGC stimulator, improves distal lung development and vascular growth, while attenuating pulmonary vascular remodeling leading to prevention of PH in a hyperoxia-induced neonatal rat model of BPD, by increasing production of cGMP in the lung. Here, SGCB is linked to bronchopulmonary dysplasia.